Brenda's Bookshelf: In Sight: My Life in Science and Biotech by Julia Levy

Each month on Brenda's Bookshelf, I share a book that has shaped my perspective—on leadership, science, business, or what drives me.

This month's pick, In Sight: My Life in Science and Biotech by Julia Levy, is more than a memoir. It's a candid look at what drug development actually requires behind the scenes.

Julia Levy helped lead QLT Inc. during the development of Visudyne, one of the first breakthrough treatments for age-related macular degeneration. This therapy preserved vision for patients who previously had few options. What stands out isn't just the scientific achievement, but the extraordinary persistence required to move an idea from laboratory discovery through clinical trials, regulatory scrutiny, and ultimately to patients.

What the Book Gets Right

The book reinforces something those of us in life sciences understand deeply, but the outside world often misses: innovation in biotech is rarely linear. Progress is shaped by uncertainty, failed experiments, funding pressures, regulatory complexity, and years of disciplined collaboration across scientific and regulatory teams.

Levy also describes the additional hurdles she faced as a woman building credibility and leadership influence in a scientific and executive environment where female voices were often underestimated. Her experience is an important reminder that scientific advancement depends not only on great ideas, but on expanding who is empowered to lead them.

Why This Stayed With Me

Reading this book strengthened my appreciation for the regulatory and scientific professionals I work with every day. Breakthrough therapies don't happen by accident. They happen because experts are willing to navigate complexity, uphold rigorous standards, and persist long after early enthusiasm fades.

In an era where innovation headlines move quickly and AI dominates conversation, In Sight brings us back to a fundamental truth: meaningful medical progress is built through patience, integrity, and human perseverance.

For anyone working in biotech, regulatory affairs, or drug development, this book offers a powerful perspective on how breakthroughs actually come to life.